Physician profile
Cong Ning
NPI 1619981297
$4,282.72
in general payments reported to CMS, 2019-2025
23 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Pediatric Endocrinology provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,083 · 2020: $323 · 2021: $728 · 2022: $1,195 · 2023: $135 · 2024: $687 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $954.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $954.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,672.70 | 2021-2022 | |
| Gilead Sciences, INC. | $609.33 | 2019-2024 | Livdelzi, Vemlidy |
| Sunovion Pharmaceuticals INC. | $294.84 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $250.00 | 2019-2020 | |
| Abbott Laboratories | $158.99 | 2020-2024 | Freestyle Libre 3 |
| Novo Nordisk INC | $153.20 | 2019-2020 | |
| Beta Bionics, INC. | $153.04 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Dexcom, INC. | $134.89 | 2023 | Dexcom G7 Gss (161) |
| Penumbra, INC. | $129.31 | 2019 | |
| Phathom Pharmaceuticals, INC. | $125.00 | 2024 | Voquezna |
| Eisai INC. | $124.98 | 2024 | |
| Genentech USA, INC. | $85.15 | 2019 | |
| Vertos Medical, INC. | $77.74 | 2019 | |
| Arbor Pharmaceuticals, INC. | $65.33 | 2019-2020 | |
| Lifescan, INC. | $63.55 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $49.01 | 2019-2020 | |
| Amphastar Pharmaceuticals, INC. | $31.34 | 2025 | |
| Abbvie INC. | $25.83 | 2020 | |
| Tolmar Pharmaceuticals, INC. | $18.82 | 2020 | |
| Medtronic USA, INC. | $16.68 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.95 | 2019 | |
| Amarin Pharma, INC. | $15.12 | 2020 | |
| Endo Pharmaceuticals INC. | $11.92 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cong Ning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.